High materiality8/10
H.C. Wainwright Reiterates Buy Rating on Pharvaris B.V. (PHVS)
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
PHVS target raised to $60; current price $30.49; UBS.
- PHVS: target $60 vs price $30.49; UBS.
Key facts
- 01
Target: $60
- 02
Posted price: $30.49
- 03
Analyst firm: UBS
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.